Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 14:56:37 GMT 2023
by
admin
on
Sat Dec 16 14:56:37 GMT 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
F5Q48O042G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
F5Q48O042G
Created by
admin on Sat Dec 16 14:56:38 GMT 2023 , Edited by admin on Sat Dec 16 14:56:38 GMT 2023
|
PRIMARY | |||
|
P51681
Created by
admin on Sat Dec 16 14:56:38 GMT 2023 , Edited by admin on Sat Dec 16 14:56:38 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_101 | 1_178 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
O | 1_6 |
O | 1_7 |
O | 1_16 |
O | 1_17 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INHIBITOR -> TARGET |
IC50
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Did not reported any cardiovascular risk, but it was failed because of unclear reasons in
a phase IIb study for rheumatoid arthritis.
Ki
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Blocks HIV infection
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT | CHEMICAL |
|